Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia
Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorApplied Biology, Inc.
About this trial
Clinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia
Eligibility criteria
Qualifiers
Diagnosed with stage I or stage II breast cancer
Scheduled but not begun, at least 4 cycles of taxane and/or anthracycline-based chemotherapy.
Ages 18-65
Able to give informed consent
Disqualifiers
Resting blood pressure outside the range of 105-140/ 55-99
Uncontrolled or severe hypertension
Female pattern hair loss or hair loss disorder
Folliculitis
Trial design
Treatments tested in this trial
- DA-020
- Placebo
- DA-020 and Hyperforin
Treatment groups
60 Participants
are divided into 3 treatment groupsLocations
2Brazil
Hospital Samel Manaus Brazil
Italy
University of Rome ("G. Marconi") Rome Italy
Sponsors and collaborators
Applied Biology, Inc.
Lead sponsor
Daniel Alain, Inc.
Collaborator
Follea International Limited
Collaborator
Source ClinicalTrials.gov